Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ryota Imanaka"'
Autor:
Testuro Ochi, Yuta Katayama, Takeshi Okatani, Ryota Imanaka, Kohei Kyo, Mitsuhiro Itagaki, Shinya Katsutani, Koji Iwato, Hideki Asaoku
Publikováno v:
Medical Mycology Case Reports, Vol 18, Iss , Pp 1-4 (2017)
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy. As zygomycosis could not be cured by liposomal amphotericin B and micafungin, left low
Externí odkaz:
https://doaj.org/article/04ecaaa23edd485081888b0ac563060d
Bosutinib-induced osteonecrosis of the jaw in a patient with chronic myeloid leukemia: a case report
Publikováno v:
Oral and Maxillofacial Surgery. 25:421-425
Medication-related osteonecrosis of the jaw (MRONJ) is an uncommon adverse drug reaction that can be induced by certain therapeutic drugs, including antiresorptive and antiangiogenic agents. Here, we describe the first case of ONJ induced by bosutini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a05cb265084040e53ca40128c76dd0
https://doi.org/10.1007/s10006-020-00931-x
https://doi.org/10.1007/s10006-020-00931-x
Autor:
Kensuke Usuki, Shoichi Ohwada, Taiga Takagi, Toru Sakura, Takeshi Takahashi, Hitoshi Ohno, Kosei Matsue, Sakura Sakajiri, Masato Murakami, Ryota Imanaka
Publikováno v:
International Journal of Hematology. 110:665-674
FMS-like tyrosine kinase 3 (FLT3) internal tandem duplication (ITD) mutations in patients with acute myeloid leukemia (AML) are associated with early relapse and poor survival. This multicenter, single-arm, two-stage phase 2 study (NCT02984995) was c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb4e8e69bec03a2c88f057f30f292a1
https://doi.org/10.1007/s12185-019-02727-6
https://doi.org/10.1007/s12185-019-02727-6
Autor:
Ryota Imanaka, Akira Ouchi, Shunsuke Kobayashi, Gen Aikawa, Hideaki Sakuramoto, Tetsuya Hoshino, Yuki Enomoto, Nobutake Shimojo, Yoshiaki Inoue
Publikováno v:
Journal of Nursing Education and Practice. 12:45
Objective: This study aimed to investigate whether inflationary noninvasive blood-pressure measurement reduces pain during blood-pressure monitoring with the lower limbs compared to the conventional noninvasive measurement method.Methods: Healthy vol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8216b888a23de4a526d2cae968616c7b
https://doi.org/10.5430/jnep.v12n7p45
https://doi.org/10.5430/jnep.v12n7p45
Autor:
Takeshi Okatani, Mitsuhiro Itagaki, Kohei Kyo, Koji Iwato, Hideki Asaoku, Testuro Ochi, Ryota Imanaka, Yuta Katayama, Shinya Katsutani
Publikováno v:
Medical Mycology Case Reports
Medical Mycology Case Reports, Vol 18, Iss, Pp 1-4 (2017)
Medical Mycology Case Reports, Vol 18, Iss, Pp 1-4 (2017)
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy. As zygomycosis could not be cured by liposomal amphotericin B and micafungin, left low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::effe5379f9e44fec16e03051f9c32c3c
http://europepmc.org/articles/PMC5501889
http://europepmc.org/articles/PMC5501889
Autor:
Yuta, Katayama, Kouhei, Kyo, Koji, Iwato, Takeshi, Okatani, Ryota, Imanaka, Mitsuhiro, Itagaki, Shinya, Katsutani, Hideki, Asaoku
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 58(11)
A 54-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) underwent hematopoietic stem cell transplantation from an HLA-matched sibling. Subsequently, she suffered from chronic graft versus host disease (GvHD) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3a82623312f24fca69ac9a6ed8968b7
https://pubmed.ncbi.nlm.nih.gov/29212977
https://pubmed.ncbi.nlm.nih.gov/29212977
Autor:
Tetsuro, Ochi, Koji, Iwato, Yuta, Katayama, Kayo, Toishigawa, Takeshi, Okatani, Ryota, Imanaka, Kohei, Kyo, Mitsuhiro, Itagaki, Shinnya, Katsutani, Hideki, Asaoku, Taiichi, Kyo
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 57(11)
An 18-year-old male was admitted to our hospital for fever, and was diagnosed with acute megakaryoblastic leukemia (AML M7) based on the presence of CD42a and CD61 positive myeloblasts in peripheral blood (PB). Induction chemotherapy at our hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a5857a5aadaf88c66a643d15223a03e7
https://pubmed.ncbi.nlm.nih.gov/27941279
https://pubmed.ncbi.nlm.nih.gov/27941279
Autor:
Fumiaki Jinnouchi, Hideki Asaoku, Ryota Imanaka, Koji Iwato, Shinya Katsutani, Yu Kochi, Tatsuji Mino, Tasuya Terasaki, Yoshimasa Suetsugu, Mitsuhiro Itagaki, Takeshi Okatani, Kohei Kyo, Tsuyoshi Muta, Masaaki Noda, Yuta Katayama
Publikováno v:
Blood. 132:5321-5321
Background: Follicular lymphoma (FL) shows indolent clinical course and the optimal management strategy includes watchful waiting (WW). To define prognostic models for WW in clinical practice, we focused on serum soluble interleukin-2 receptor (sIL-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f68416b161710c2c85f830618924fd19
https://doi.org/10.1182/blood-2018-99-116016
https://doi.org/10.1182/blood-2018-99-116016
Autor:
Koji Iwato, Tsuyoshi Muta, Fumiaki Jinnouchi, Hideki Asaoku, Yuta Katayama, Shinya Katsutani, Takeshi Okatani, Yu Kochi, Kohei Kyo, Tatsuya Terasaki, Tatsuji Mino, Mitsuhiro Itagaki, Ryota Imanaka
Publikováno v:
Blood. 132:2095-2095
Background: Indications for allogeneic hematopoietic stem cell transplantation (allo-HCT) with reduced-intensity conditioning (RIC) have expanded widely for elderly patients and those with comorbidities. However, the optimal RIC regimen remains uncer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e1d4a5baa12a23b2a5cc93dfd426e58
https://doi.org/10.1182/blood-2018-99-113461
https://doi.org/10.1182/blood-2018-99-113461
Autor:
Taiichi Kyo, Tetsuro Ochi, Kouhei Kyo, Yuta Katayama, Mitsuhiro Itagaki, Takeshi Okatani, Ryota Imanaka, Kayo Toishigawa
Publikováno v:
Blood. 126:1340-1340
Introduction Patients with AML-MRC are almost older and highly resistant to chemotherapy, so that they are thought to be not eligible for intensive chemotherapy (IC) compared with de novo AML. Reduced intensity chemotherapy, such as low-dose cytarabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::782d99965efec1ca619693fadccc9b7a
https://doi.org/10.1182/blood.v126.23.1340.1340
https://doi.org/10.1182/blood.v126.23.1340.1340